Nanosonics Limited (NAN) is involved in the manufacturing and distribution of the trophon EPR ultrasound probe disinfector and its associated consumables and accessories. It is also involved in research, development and commercialization of infection control and decontamination products and related technologies.

Investment summary

Nanosonics limited has a strong balance sheet, with positive cashflow and net cash. It has a strong technological niche and is a growing asset for healthcare services looking to manage infection prevention practices. While it doesn't pay a dividend, it is investing in the distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories.

Current Products and related technologies

Developed and commercialised a unique automated disinfection technology, trophon®, representing the first major innovation in high level disinfection for ultrasound probes in more than 20 years.

The company also sells the associated infection prevention and control consumables for use in the machine. Products are sold to hospitals to help manage the spread to infections in Australia and overseas markets including North America, UK and Europe.

Want to see other interesting ASX Healthcare Shares stocks?